Found: 14
Select item for more details and to access through your institution.
Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.
- Published in:
- Pediatric Obesity, 2019, v. 14, n. 5, p. N.PAG, doi. 10.1111/ijpo.12495
- By:
- Publication type:
- Article
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
- Published in:
- Bipolar Disorders, 2012, v. 14, n. 1, p. 31, doi. 10.1111/j.1399-5618.2011.00975.x
- By:
- Publication type:
- Article
Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2254, doi. 10.1111/head.14011
- By:
- Publication type:
- Article
Asenapine pharmacokinetics and tolerability in a pediatric population.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 2677, doi. 10.2147/DDDT.S171475
- By:
- Publication type:
- Article
Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder.
- Published in:
- JAMA: Journal of the American Medical Association, 1998, v. 280, n. 20, p. 1752, doi. 10.1001/jama.280.20.1752
- By:
- Publication type:
- Article
PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420911296
- By:
- Publication type:
- Article
PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420911296
- By:
- Publication type:
- Article
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 12, p. 1666, doi. 10.7326/M22-1438
- By:
- Publication type:
- Article
Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, n. 2, p. 350, doi. 10.1093/schbul/sby049
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Single-Dose Inhaled Loxapine in Children and Adolescents.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 10, p. 1244, doi. 10.1002/jcph.932
- By:
- Publication type:
- Article
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 9, p. 985, doi. 10.1002/jcph.502
- By:
- Publication type:
- Article
Effect of Raltegravir on the Pharmacokinetics of Methadone.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 12, p. 1461, doi. 10.1177/0091270009360981
- By:
- Publication type:
- Article
Long-term open-label safety study of galcanezumab in patients with episodic or chronic cluster headache.
- Published in:
- Cephalalgia, 2022, v. 42, n. 11/12, p. 1225, doi. 10.1177/03331024221103509
- By:
- Publication type:
- Article
Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder.
- Published in:
- Psychopharmacology, 2012, v. 221, n. 4, p. 601, doi. 10.1007/s00213-011-2604-x
- By:
- Publication type:
- Article